⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CNXU News
Conexeu Sciences Inc. Common Stock
The GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It.
prnewswire.com
EQNR
TALO
VLO
CNXU
PBF
A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next
globenewswire.com
CNXU
FA
ANAB
CVE
MPC
The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
globenewswire.com
CNXU
One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics
prnewswire.com
NVO
EOLS
ABBV
CNXU
Form 8-K
sec.gov
CNXU
A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill It
prnewswire.com
NVO
ABBV
CNXU
LLY
A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill
globenewswire.com
CNXU
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
globenewswire.com
CNXU
ABBV
LLY
ESTA
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
globenewswire.com
CNXU
ESTA
INMD
ABBV
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
globenewswire.com
CNXU